Media

Trianni, Inc. and Simon Fraser University Announce 
Licensing Agreement for The Trianni Mouse™

Full Release San Francisco, CA, USA, September 18, 2018 – Trianni, Inc. (“TRIANNI”) and Simon Fraser University (“SFU”) announced today […]

Continue reading

Gilead Enters Licensing Agreement With Trianni for Use of Trianni Transgenic Human Monoclonal Antibody Discovery Platform

FOSTER CITY, Calif. & SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)–Sep. 4, 2018– Gilead Sciences, Inc. (NASDAQ: GILD) and Trianni, Inc. (“TRIANNI”) […]

Continue reading

Trianni, Inc. Signs Licensing Agreement with Straterx, Inc.

San Francisco, CA, USA, June 12, 2018 – Trianni, Inc. (“TRIANNI”) announced today that it has entered into a license […]

Continue reading

Mouse Powered Progress: Producing Humanized Monoclonal Antibodies With Transgenic Mice

Antibodies are a critical feature of the human adaptive immune response. New immunotherapies require the production of selective and non-autoimmunogenic […]

Continue reading

Trianni, Inc. and NovaRock Biotherapeutics, Ltd. Announce Licensing Agreement

San Francisco, CA, USA, March 28, 2018 – Trianni, Inc. (“TRIANNI”) and NovaRock Biotherapeutics, Ltd. (“NOVAROCK”) jointly announced today that […]

Continue reading

ENTHERA and TRIANNI Announce Licensing Agreement

San Francisco, CA, USA and Milano, Italy, March 22, 2018 – Trianni, Inc. (“TRIANNI”) and Enthera, S.r.l. (“ENTHERA”) jointly announced […]

Continue reading

TRIANNI sponsors The Werner Müller Award for Excellence in Immunology

San Francisco, CA, USA. and Berlin, Germany, December 6, 2017 –Trianni, Inc. (“TRIANNI”) announced that it will sponsor the Werner […]

Continue reading

Trianni and Juno Therapeutics Sign Licensing Agreement for Use of Trianni Transgenic Mouse Platform

San Francisco, CA, USA, October 18, 2017– Trianni, Inc. (“TRIANNI”).  today announced that Juno Therapeutics (NASDAQ: JUNO) has entered into […]

Continue reading

TRIANNI Signs Agreement with Massachusetts General Hospital for Use of The Trianni Mouse™ in HIV Vaccine Research

San Francisco, CA, USA, June 1 2017 – Trianni, Inc. (“TRIANNI”) announced today that it has entered into an agreement […]

Continue reading

TRIANNI and Olympic Protein Technologies Sign License Agreement for The Trianni Mouse™

San Francisco, CA and Seattle, WA, USA., May 24, 2017 –Trianni, Inc. (“TRIANNI”) and Olympic Protein Technologies (“Olympic”) jointly announced […]

Continue reading